Selinexor and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Lung Cancer

Clinical trial NCT02536495 · WITHDRAWN

Trial details

NCT number: NCT02536495
Sponsor: Erin Bertino
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Recurrent Squamous Cell Lung Carcinoma Stage IV Squamous Cell Lung Carcinoma

Start date: 2015-09-01
Primary completion: 2018-12-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.